#### 4A.4.6.21 RXG-21 Substance Manufacturer Name (CWE) 01131

Components: &lt;Identifier (ST)> ^ &lt;Text (ST)> ^ &lt;Name of Coding System (ID)> ^ &lt;Alternate Identifier (ST)> ^ &lt;Alternate Text (ST)> ^ &lt;Name of Alternate Coding System (ID)> ^ &lt;Coding System Version ID (ST)> ^ &lt;Alternate Coding System Version ID (ST)> ^ &lt;Original Text (ST)> ^ &lt;Second Alternate Identifier (ST)> ^ &lt;Second Alternate Text (ST)> ^ &lt;Name of Second Alternate Coding System (ID)> ^ &lt;Second Alternate Coding System Version ID (ST)> ^ &lt;Coding System OID (ST)> ^ &lt;Value Set OID (ST)> ^ &lt;Value Set Version ID (DTM)> ^ &lt;Alternate Coding System OID (ST)> ^ &lt;Alternate Value Set OID (ST)> ^ &lt;Alternate Value Set Version ID (DTM)> ^ &lt;Second Alternate Coding System OID (ST)> ^ &lt;Second Alternate Value Set OID (ST)> ^ &lt;Second Alternate Value Set Version ID (DTM)>

Definition: This field contains the manufacturer of the medical substance administered.

**Note:** For vaccines, code system MVX may be used to code this field (see section _4A.7.1_, "_Vaccine administration data_"). This field may be used if the manufacturer of the substance is not identified by the code used in RXA-5-administered code.
